Immunotherapy Now and Future for Metastatic Renal Cell Carcinoma Jianjun Gao, MD, PhD

Immunotherapy Now and Future for Metastatic Renal Cell Carcinoma Jianjun Gao, MD, PhD

Panel Discussion Moderated by Christopher G. Wood, M.D., FACSПодробнее

Panel Discussion Moderated by Christopher G. Wood, M.D., FACS

Recent Advances in Renal Cell CarcinomaПодробнее

Recent Advances in Renal Cell Carcinoma

Summary of Immunotherapy CME Presentation: Xin Gao, MDПодробнее

Summary of Immunotherapy CME Presentation: Xin Gao, MD

Upfront Immunotherapy for Metastatic Kidney CancerПодробнее

Upfront Immunotherapy for Metastatic Kidney Cancer

Dr JianJun Gao discusses papillary renal cell carcinoma (pRCC) and prospective immunotherapyПодробнее

Dr JianJun Gao discusses papillary renal cell carcinoma (pRCC) and prospective immunotherapy

The Renaissance of Immunotherapy for Metastatic Disease Jianjun Gao, M.D., Ph.D.Подробнее

The Renaissance of Immunotherapy for Metastatic Disease Jianjun Gao, M.D., Ph.D.

Immunotherapy For Kidney Cancer: A New Renaissance? Jianjun Gao, MD, PhDПодробнее

Immunotherapy For Kidney Cancer: A New Renaissance? Jianjun Gao, MD, PhD

Dr JianJun Gao provides an overview of renal medullary carcinoma (RMC) and kidney cancer treatmentsПодробнее

Dr JianJun Gao provides an overview of renal medullary carcinoma (RMC) and kidney cancer treatments

Immunotherapy in Kidney CancerПодробнее

Immunotherapy in Kidney Cancer

Dr. Sznol Discusses Immunotherapy in Non-Clear Cell Renal CancerПодробнее

Dr. Sznol Discusses Immunotherapy in Non-Clear Cell Renal Cancer

Dr. Albiges on Immunotherapy in Renal Cell CarcinomaПодробнее

Dr. Albiges on Immunotherapy in Renal Cell Carcinoma

Risk Stratification for Metastatic Renal Cell CarcinomaПодробнее

Risk Stratification for Metastatic Renal Cell Carcinoma

Will immunotherapy take over the treatment landscape of patients high-risk renal cell carcinoma?Подробнее

Will immunotherapy take over the treatment landscape of patients high-risk renal cell carcinoma?

Current and Emerging Salvage Therapies for Metastatic Renal Cell Carcinoma Nazir M. Tannir, MD, FACPПодробнее

Current and Emerging Salvage Therapies for Metastatic Renal Cell Carcinoma Nazir M. Tannir, MD, FACP

Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)Подробнее

Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)

Immunotherapy of Renal Cell CarcinomaПодробнее

Immunotherapy of Renal Cell Carcinoma

Surgery after immunotherapy for renal cell carcinomaПодробнее

Surgery after immunotherapy for renal cell carcinoma

The Role of Tyrosine Kinase Inhibitors and mTOR InhibitorsПодробнее

The Role of Tyrosine Kinase Inhibitors and mTOR Inhibitors

Exploring the impact of gut microbiota on immunotherapy response in renal cell carcinomaПодробнее

Exploring the impact of gut microbiota on immunotherapy response in renal cell carcinoma